A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these profiles privately for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could result in individuals injecting substances of unknown origin.
Several experts stated the demand for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.
Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.
Service Response and Content Elimination
Based on TikTok, the service has removed problematic content and banned related keywords and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.
Digital Trading Operations
Research also found communities with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, positive reviews and detailed instructions for preparing or administering at home.
Within moments of joining one community, a seller shared WhatsApp details, where most purchases take place. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, health issues or past usage.
Item Information and Costs
Inside these communities, posts show dark colored parcels with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Measures
A representative for Telegram said it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her staff has already encountered individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose users to possibly serious medical dangers”.
